Intravenous Ketamine Use for Patients With Chronic Pain Conditions : Topics in Pain Management

Journal Logo

Erratum

Intravenous Ketamine Use for Patients With Chronic Pain Conditions

Topics in Pain Management 36(5):p 10, December 2020. | DOI: 10.1097/01.TPM.0000723836.68182.60
  • Free

In Topics in Pain Management vol. 36, no. 5 (November 2020), an error appeared in the following statement on page 4: “However, unlike other anesthetics, ketamine does not interact with D-aminobutyric acid (GABA) receptors.”

The correct statement is as follows: “However, unlike other anesthetics, ketamine does not interact with γ-aminobutyric acid (GABA) receptors.”

Reference:

Millicker M, Starkweather A. Intravenous ketamine use for patients with chronic pain conditions. Topics in Pain Management 2020;36(4):1–8.
© 2020 Wolters Kluwer Health, Inc. All rights reserved.